CYP2D6 is a key cytochrome P450 enzyme involved in metabolizing many neurotransmitters (e.g., serotonin, dopamine, norepinephrine) and numerous drugs. A direct causal role of CYP2D6 variants in 'stress' as a clinical condition is not well established. The enzyme's activity can affect the metabolism of antidepressants (e.g., SSRIs) or beta-blockers used in stress management. Poor metabolizers may experience higher drug levels and more side effects, potentially increasing subjective stress. Conversely, some studies link CYP2D6 polymorphisms to personality traits like anxiety, but effect sizes are small and evidence is mostly mechanistic or GWAS-based. Importantly, a genetic test alone cannot diagnose stress or justify personalized therapy without medical supervision. Lifestyle, environment, and psychosocial factors dominate. Evidence is rated 'mechanistic' – biological plausibility exists, but direct clinical recommendations are not supported.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-9021634634c240ac59930a2d